NUZ 0.00% 22.5¢ neurizon therapeutics limited

Ann: Phase IIb Dog Trial Achieves Interim Clinical Endpoints, page-77

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,430 Posts.
    lightbulb Created with Sketch. 1513
    Now they've got the data of two phase 2 dog cancer trials, last year's and this year's (b) with the reduced dosages. But hey, there's "nothing" to see (or hear) around here, lol
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.